Published 2 November 2021
A health technology company, RxAll, has announced the launch of an authentication platform for regulators and pharmacies to authenticate medicines.
The company disclosed this in a statement as it launched its online and physical service to the public.
It said its move to establish a presence in Nigeria was an important step as it worked towards tackling counterfeit medication.
The company said it would “work with drug regulatory agencies and other stakeholders to reduce fake medicines and make sure that patients access affordable high-quality verified drugs, and help pharmaceutical companies make more sales”.
The Co-founder and Chief Executive Officer, RxAll, Adebayo Alonge, said, “We provide an authentication platform through which regulators/pharmacies can authenticate medicines.
“Our journey to the market is based on our understanding of the challenges confronting the industry and the people. We have created solutions to address issues of wrong consumption of poor-quality drugs and accessibility to appropriate drugs through the RxAll corporate brand that will ensure interface with all members of the pharma supply value chain.”
Alonge added the company was in a country with a range of tech-driven products and services that it will introduce to various sectors of the society based on the readiness of the market.
According to Alonge, one of the company’s tech-driven products is the RxScanner, which is designed for instant drug quality testing.
He said the device was designed to ensure an increase in worldwide access to affordable quality medications and to identify the quality of prescription drugs in 20 seconds without destroying the sample.
“The company has a drug delivery platform, Rxdelivered, which enables pharmacies and patients to buy affordable and authenticated drugs from its wholesale network on cash or credit with self-pickup and deliver-to-me options,” he added.
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from PUNCH.
Contact: [email protected]